Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
299 Leser
Artikel bewerten:
(1)

INTENT Secures Investment From BioGenerator Ventures, Advancing the Ag Tech Ecosystem in St. Louis

Series A Investment to Help Accelerate Technology Expansion for INvision Trials and Apogee

ST. LOUIS, MO / ACCESSWIRE / August 2, 2023 / Ag industry pioneer and St. Louis-based INTENT announced an equity investment from BioGenerator Ventures to help accelerate industry-changing advancements in agriculture, with particular emphasis on the commercial expansion of INvision Trials and Apogee technologies.

INvision Trials Logo

INvision Trials is a new software that aims to revolutionize field trials in the agriculture industry. Built on the Apogee infrastructure, INvision Trials offers a completely redesigned interface for project management, presenting a geospatial visualization of all aspects of a field project in a scalable system that delivers consistent, quality data, and powerful insights with speed and agility.

"This partnership with BioGenerator Ventures is another step forward to expanding and enabling the ag tech ecosystem in St. Louis," said Randall Barker, CEO and co-founder of INTENT. "INTENT helps to reduce time and mitigate risk associated with advancing agriculture innovations, by leveraging our advanced technology solutions. The future of agriculture is filled with potential and moving faster than ever."

INTENT is the industry's trusted partner to move those innovations forward faster and more successfully, combining their deep experience with purpose-built technology solutions, while enabling the company to ground truth at scale with their expansive farmer network.

Ag tech is an area of focus for BioGenerator Ventures, whose portfolio includes St. Louis-based companies such as Solis Agrosciences, Aferna Bio, Plastomics, Impetus Ag, and Agragene. BioGenerator Ventures is building a portfolio of new technology solutions, while simultaneously creating and investing in businesses that provide innovative services to Ag tech innovators.

With the investment from BioGenerator Ventures, Matt Helms, Managing Director of BioGenerator Ventures, joins the INTENT board of directors.

"BioGenerator Ventures is excited to be part of INTENT and sees great value in the insights the company's technology provides to both innovators and farmers," said Helms. "INTENT helps translate innovative new technologies to the real-world challenges that farmers must overcome."

About INTENT:
INTENT is an agriculture software and services company, founded in 2016, that supports the realization of new innovations by connecting customers in agriculture, and those investing in agriculture, with farmers. INTENT helps clients unlock growth by focusing on comprehensive data, farmer experience, go-to-market strategy and digital innovation For more information, visit https://intent.ag/

About BioGenerator Ventures:
BioGenerator Ventures, the investment arm of BioSTL, creates, builds, and invests in companies that are solving important problems in healthcare and agriculture. For additional information, visit https://www.biogeneratorventures.com/.

Contact Information:

Sheena Pitura
VP - Strategy & Marketing
sheena.pitura@intent.ag

SOURCE: INTENT

.

View source version on accesswire.com:
https://www.accesswire.com/771671/INTENT-Secures-Investment-From-BioGenerator-Ventures-Advancing-the-Ag-Tech-Ecosystem-in-St-Louis

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2023 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.